UBS AM’s Hinge Health HNGE Stock Holding History

UBS AM’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$939K	Buy	24,363 +7,269	+43%	+$302K	﹤0.01%	2363
2025 Q4	$794K	Buy	17,094 +2,694	+19%	+$130K	﹤0.01%	2211
2025 Q3	$707K	Buy	+14,400	New	+$753K	﹤0.01%	2101

Other funds holding HNGE

IHG

Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

12CM

11.2 Capital Management Las Vegas, Nevada $143M AUM

DMC

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

UBS AM's HNGE Position: Q1 2026 in Review

UBS AM increased its Hinge Health (HNGE) stake by 43% in Q1 2026, buying an estimated $302K and bringing the position to 24,363 shares worth $939K. The position accounts for ﹤0.01% of the portfolio, ranked #2363.

UBS AM first reported a position in HNGE in Q3 2025 and has held it in 3 quarters since. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

UBS AM held 24,363 shares of Hinge Health worth $939K as of Q1 2026.
UBS AM bought 7,269 Hinge Health shares in Q1 2026, an estimated $302K.
Hinge Health made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #2363 holding.
UBS AM first reported a position in Hinge Health in Q3 2025 and has held it in 3 quarters since.
203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.